News from innocoll, inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Apr 17, 2013, 07:00 ET

Innocoll enters into Exclusive Licensing and Distribution Agreement with Biomet 3i for CollaCare® Dental product range.

 Innocoll, Inc. announced it has entered into an exclusive License and Distribution Agreement with Biomet 3i for its range of CollaCare Dental...

Feb 19, 2013, 07:00 ET

Innocoll Announces Launch of its New CollaCare® Website

 Innocoll, Inc. announced the launch of its new CollaCare website, www.collacareproducts.com.  The new, standalone website is designed to...

Feb 06, 2013, 07:00 ET

Innocoll Announces Publication of Clinical Data for XaraColl® and Regulatory Approval of CollaGUARD® in India

 Innocoll, Inc. announced that the following series of three articles presenting Phase 2 clinical data for its bupivacaine-collagen implant,...

Apr 03, 2012, 07:00 ET

Innocoll Provides Update of Regulatory and Partnering Activities for CollaGUARD® Adhesion Barrier and Launches New Product Website

ASHBURN, Va., April 3, 2012 /PRNewswire/ –– Innocoll Inc. announces that its distribution network for CollaGUARD has now been expanded...

Feb 17, 2012, 07:00 ET

Innocoll Announces Successful End-of-Phase 2 Meeting with FDA for XaraColl® and Agreement of the Phase 3 Program

 Innocoll, Inc. announced that it has held an End-of-Phase 2 meeting with the FDA to present the results of the Phase 2 clinical studies...

Feb 01, 2012, 07:00 ET

Innocoll Enters CollaGUARD® Distribution Partnership With Flynn Pharma Ltd in the UK and Inresa Arzneimittel GmbH in Germany

 Innocoll Inc. announced it has entered into a License and Distribution Agreement with Flynn Pharma Ltd. in the United Kingdom and with Inresa...

Nov 15, 2011, 07:16 ET

Innocoll Enters Partnership with Merus Labs in Canada for the Distribution of CollaGUARD

Innocoll Inc. announced it has entered into a License and Distribution Agreement with Merus Labs Inc. in Canada for CollaGUARD surgical adhesion...

Oct 19, 2011, 07:00 ET

Innocoll Enters Partnership With Pioneer Pharma in China for the Distribution of CollaGUARD

Innocoll, Inc. announced it has entered into a License and Distribution Agreement with Pioneer Pharma in China for CollaGUARD surgical adhesion...

Oct 11, 2011, 07:00 ET

Innocoll Announces European Approval for CollaGUARD®, Surgical Adhesion Barrier

Innocoll, Inc. announces the approval of CollaGUARD surgical adhesion barrier for the prevention of postoperative adhesions following abdominal and...

Sep 19, 2011, 07:00 ET

Innocoll Provides an Update on its Range of Advanced Wound Care and Related Collagen-based Products

Innocoll, Inc. announced the following update for its range of advanced wound care and related collagen-based products. Based on a series of recent...

Sep 13, 2011, 07:00 ET

Innocoll Announces Top-line Results from its Phase 2 Clinical Trial Investigating XaraColl® for the Management of Post-operative Pain and Receives "Notice of Allowability" for XaraColl U.S. Patent Application

Innocoll, Inc. announced top-line results from its phase 2 clinical trial investigating XaraColl for the management of post-operative pain and also...

Jul 13, 2010, 07:00 ET

Innocoll Submits SPA for Cogenzia(TM) Phase III Clinical Trials for the Adjuvant Treatment of Diabetic Foot Infections

Innocoll, Inc. announced that its wholly-owned subsidiary, Innocoll Technologies Ltd., has submitted a Special Protocol Assessment (SPA) for a...

Jun 17, 2010, 07:00 ET

Innocoll Announces Appointment of Anthony H. Wild Ph.D. to Chairman of the Board

Innocoll Inc. today announced that its board of directors appointed Anthony H. Wild, Ph.D. to the post of chairman of the board, effective...

Jun 18, 2009, 07:00 ET

Innocoll Announces Provisional Findings From Its Three Phase 2 Clinical Trials Investigating CollaRx(R) GENTAMICIN TOPICAL for the Treatment and Prevention of Diabetic Foot Infections

Innocoll, Inc., a privately-held biopharmaceutical company, announced positive provisional findings from its three phase 2 clinical trials...

Mar 31, 2009, 07:00 ET

Innocoll, Inc. Files 510 (k) Application for CollaRx Lidocaine Sponge

- Innocoll, Inc. announced that its wholly-owned subsidiary, Innocoll Pharmaceuticals, has filed a US 510k application for its CollaRx(TM) Lidocaine...

Mar 19, 2009, 07:00 ET

Innocoll Announces Dosing of Last Patient in Second US Phase 3 Clinical Trial to Investigate GENTAMICIN SURGICAL IMPLANT for Prevention of Surgical Site Infections in Colorectal Surgery Patients

Innocoll, Inc., a privately-held biopharmaceutical company, announced that the last patient has been dosed in the second of two ongoing U.S. phase...

Mar 16, 2009, 07:00 ET

Innocoll Announces Dosing of Last Patient in US Phase 3 Clinical Trial to Investigate GENTAMICIN SURGICAL IMPLANT for Prevention of Surgical Site Infections in Cardiac Surgery Patients

Innocoll, Inc., a privately-held biopharmaceutical company, announced that the last patient has been dosed in the first of two ongoing U.S. phase 3...

Nov 17, 2008, 07:00 ET

Innocoll Receives Fast Track Designation for Gentamicin Surgical Implant

Innocoll, Inc., a privately-held biopharmaceutical company, announced that the FDA has designated Gentamicin SURGICAL Implant as a Fast Track...

Jul 28, 2008, 01:00 ET

Innocoll Announces Dosing of First Patient in a Third US Phase 2 Clinical Trial to Investigate CollaRx(R) BUPIVACAINE SURGICAL IMPLANT for the Management of Post-Operative Pain

ASHBURN, Va., July 28 /PRNewswire/ -- Innocoll, Inc., a privately-held biopharmaceutical company, announced that the third of a series of...

Jul 21, 2008, 01:00 ET

Innocoll Appoints Anthony H. Wild Ph.D. to Its Board of Directors

ASHBURN, Va., July 21 /PRNewswire/ -- Innocoll Inc. today announced that Anthony H. Wild, Ph.D. has been appointed to its board of directors....

Organizations in the News

The organizations with the most activity in PR Newswire's News Room

ReportBuyer
Research and Markets
Investor-Edge